ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Nevada » Pulmonary Disease

Top Pulmonary Disease Prescribers in Nevada

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RACHAKONDA PRABHU M.D.

Pulmonary Disease

9,024

$1.01M

595
384 are 65+

16%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 63%

$112
Average prescription price

Avg: $210

CHARLES MCPHERSON MD

Pulmonary Disease

2,538

$383K

320
262 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 63%

$151
Average prescription price

Avg: $210

JOHN WOJCIK MD

Pulmonary Disease

2,355

$617K

272
212 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 63%

$262
Average prescription price

Avg: $210

GUY FOSTER MD

Pulmonary Disease

2,288

$367K

260
214 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 63%

$160
Average prescription price

Avg: $210

ROBERT MCDONALD MD

Pulmonary Disease

2,216

$473K

286
241 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 63%

$214
Average prescription price

Avg: $210

GEORGE TU MD

Pulmonary Disease

2,000

$656K

341
287 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 63%

$328
Average prescription price

Avg: $210

WALTER WILLOUGHBY MD

Pulmonary Disease

1,701

$308K

268
231 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 63%

$181
Average prescription price

Avg: $210

JOHN PINTO MD FCCP

Pulmonary Disease

1,500

$487K

223
184 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 63%

$324
Average prescription price

Avg: $210

JAMES HSU MD

Pulmonary Disease

1,476

$528K

230
189 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 63%

$358
Average prescription price

Avg: $210

NARESH SINGH MD

Pulmonary Disease

1,399

$206K

185
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 63%

$147
Average prescription price

Avg: $210

JOHN COLLIER MD

Pulmonary Disease

1,376

$420K

267
232 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 63%

$305
Average prescription price

Avg: $210

PAUL STEWART MD

Pulmonary Disease

1,195

$228K

196
153 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 63%

$191
Average prescription price

Avg: $210

SURESH KHILNANI MD

Pulmonary Disease

1,144

$281K

220
149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

75%
prescriptions for brand name drugs

Avg: 63%

$245
Average prescription price

Avg: $210

SYED AKBARULLAH MD

Pulmonary Disease

1,116

$399K

199
161 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 63%

$357
Average prescription price

Avg: $210

KENNETH MOONEY M.D.

Pulmonary Disease

1,115

$187K

243
199 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 63%

$167
Average prescription price

Avg: $210

MICHAEL LUCIA MD

Pulmonary Disease

1,061

$163K

190
159 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

64%
prescriptions for brand name drugs

Avg: 63%

$154
Average prescription price

Avg: $210

ROBERT LAMPERT MD

Pulmonary Disease

1,059

$296K

219
182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 63%

$279
Average prescription price

Avg: $210

CHARLES HELD MD

Pulmonary Disease

874

$139K

127
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 63%

$159
Average prescription price

Avg: $210

MURAD JUSSA M.D.

Pulmonary Disease

774

$381K

139
120 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

74%
prescriptions for brand name drugs

Avg: 63%

$492
Average prescription price

Avg: $210

MICHAEL SCHLACHTER M.D.

Pulmonary Disease

731

$194K

162
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 63%

$265
Average prescription price

Avg: $210

THOMSON CHEMPLAVIL MD

Pulmonary Disease

508

$262K

106
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

64%
prescriptions for brand name drugs

Avg: 63%

$517
Average prescription price

Avg: $210

SALVATORE GUARNERA M.D.

Pulmonary Disease

499

$97.2K

103
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 63%

$195
Average prescription price

Avg: $210

ANTONIO FLORES ERAZO MD

Pulmonary Disease

491

$81.9K

128
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

82%
prescriptions for brand name drugs

Avg: 63%

$167
Average prescription price

Avg: $210

JAN PRING D.O.

Pulmonary Disease

416

$45.2K

115
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 63%

$109
Average prescription price

Avg: $210

RAGHAVENDRA KRISHNAMURTHY MD

Pulmonary Disease

347

$55.2K

70
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 63%

$159
Average prescription price

Avg: $210

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank